Syneron Medical Ltd

Syneron Medical Ltd manufactures radiofrequency-based aesthetic devices for non-invasive skin treatments, including systems for body contouring, skin tightening, and wrinkle reduction. Their portfolio includes applicators and power systems designed for procedures such as fat reduction, cellulite treatment, and facial rejuvenation, often targeting subcutaneous tissue. The UltraShape System and POLARIS series are among the devices used for deep tissue heating and volume reduction, while the AURORA series focuses on facial and neck rejuvenation. CO2-based devices like the EMATRIX CO2 and CO2RE System are intended for skin resurfacing and tightening through controlled laser ablation.

All listed devices fall under FDA Class II regulation, requiring 510(k) clearance for market authorisation in the United States. The company’s products are not registered in other major global databases such as the EU’s MDR or the Canadian MDDR. Syneron Medical Ltd operates from the United States, adhering to US regulatory standards for medical device compliance.

AI-generated from registry data, 20 Sep 2026. Not verified by deviCERTS or the manufacturer.